Business Description
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Business History
Price Overview
Last updated: May 11, 2026 1:49pm (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 0.03
Total Equity: $1.52B
Shares: 391,136,000
Total Debt: $194.10M
Cash: $248.64M
EBITDA: $78.78M
Total Debt: $194.10M
Cash: $248.64M
Revenue: $1.42B
Revenue: $1.42B
Revenue: $1.42B
Total Equity: $1.52B
Tax Rate: 21.8%
Equity: $1.52B
Total Debt: $194.10M
Cash: $248.64M
Current Liabilities: $251.96M
Long-Term Debt: $148.55M
Total Debt: $194.10M
Total Equity: $1.52B
Shares: 391,136,000
Shares: 391,136,000
CapEx: -$36.13M
Shares: 391,136,000
Stock Price: $7.64
Net Income: $9.66M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $667.5M | $859.5M | $1.1B | $1.3B | $1.4B |
| Cost of Revenue | $466.0M | $622.5M | $753.6M | $848.6M | $1.0B |
| Gross Profit | $201.5M | $237.0M | $302.1M | $402.4M | $406.3M |
| Operating Expenses | $487.9M | $447.2M | $491.2M | $434.0M | $380.6M |
| Operating Income | -$286.4M | -$210.2M | -$189.1M | -$31.6M | $25.7M |
| Net Income | -$307.2M | -$215.6M | -$186.3M | -$57.4M | $9.7M |
| EBITDA | -$240.1M | -$143.6M | -$104.9M | $39.9M | $78.8M |
| EPS | $-1.05 | $-0.61 | $-0.51 | $-0.15 | $0.03 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $148.0M | $108.6M | $78.8M | $154.6M | $248.6M |
| Total Current Assets | $266.5M | $233.2M | $225.7M | $312.5M | $416.2M |
| Total Assets | $1.9B | $2.2B | $2.1B | $2.1B | $2.2B |
| Current Liabilities | $116.8M | $176.0M | $202.9M | $228.9M | $252.0M |
| Long-Term Debt | $157.4M | $225.1M | $280.3M | $279.8M | $148.6M |
| Total Liabilities | $382.1M | $655.1M | $681.0M | $672.0M | $682.9M |
| Total Equity | $1.5B | $1.5B | $1.4B | $1.4B | $1.5B |
| Retained Earnings | -$357.1M | -$572.6M | -$760.8M | -$818.3M | -$808.6M |
Cash Flow (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $9.4M | $52.8M | -$16.9M | $107.3M | $146.2M |
| Capital Expenditure | -$94.5M | -$79.3M | -$40.5M | -$21.6M | -$36.1M |
| Free Cash Flow | -$85.1M | -$26.5M | -$57.4M | $85.7M | $110.0M |
| Acquisitions (net) | -$99.6M | -$60.2M | -$19.8M | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $-904,000 | $0 | $0 | $0 |
| Net Change in Cash | $129.2M | -$39.4M | -$29.8M | $75.7M | $94.1M |
Analyst Estimates (Annual)
| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$1.4B $1.4B – $1.4B
|
$1.7B $1.6B – $1.7B
|
$1.9B $1.9B – $1.9B
|
$2.2B $2.2B – $2.2B
|
| EBITDA |
$571.2M $563.6M – $582.8M
|
$665.6M $661.6M – $673.8M
|
$759.7M $751.5M – $775.9M
|
$868.8M $866.7M – $871.0M
|
| Net Income |
-$1.7M -$1.7M – -$1.7M
|
$56.5M $30.5M – $61.1M
|
$80.5M $57.9M – $84.7M
|
$161.7M $137.8M – $185.6M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +28.8% | +22.8% | +18.5% | +13.9% |
| Gross Profit Growth | +17.6% | +27.5% | +33.2% | +1.0% |
| Operating Income Growth | +26.6% | +10.0% | +83.3% | +181.3% |
| Net Income Growth | +29.8% | +13.6% | +69.2% | +116.8% |
| EBITDA Growth | +40.2% | +26.9% | +138.0% | +97.6% |
Insider Trading (Recent)
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-04-23 | Bessler Robert | S-Sale | 3,876.00 | $7.00 | $27,132 |
| 2026-04-24 | Bessler Robert | S-Sale | 31,074.00 | $7.05 | $219,072 |
| 2026-04-23 | Bessler Robert | S-Sale | 3,876.00 | $7.00 | $27,132 |
| 2026-04-24 | Bessler Robert | S-Sale | 31,073.00 | $7.05 | $219,065 |
| 2026-04-21 | Bessler Robert | S-Sale | 2,550.00 | $7.01 | $17,876 |
| 2026-04-21 | Bessler Robert | S-Sale | 2,551.00 | $7.01 | $17,883 |
| 2026-04-01 | Pardo Ryan | F-InKind | 9,376.00 | $6.37 | $59,725 |
| 2026-03-24 | McGroarty Ryan | F-InKind | 24,255.00 | $6.45 | $156,445 |
| 2026-03-17 | McGroarty Ryan | F-InKind | 47,594.00 | $6.89 | $327,923 |
| 2026-03-09 | Burdick Kenneth A | A-Award | 706,960.00 | $0.00 | $0 |
| 2026-03-09 | Burdick Kenneth A | F-InKind | 278,192.00 | $6.91 | $1.9M |
| 2026-03-09 | Burdick Kenneth A | A-Award | 33,544.00 | $0.00 | $0 |
| 2026-03-09 | Burdick Kenneth A | F-InKind | 13,201.00 | $6.91 | $91,219 |
| 2026-03-09 | Burdick Kenneth A | F-InKind | 35,816.00 | $6.91 | $247,489 |
| 2026-03-09 | Bourdon David | A-Award | 205,550.00 | $0.00 | $0 |
| 2026-03-09 | Bourdon David | F-InKind | 86,024.00 | $6.91 | $594,426 |
| 2026-03-09 | Bourdon David | A-Award | 122,994.00 | $0.00 | $0 |
| 2026-03-09 | Bourdon David | F-InKind | 51,474.00 | $6.91 | $355,685 |
| 2026-03-09 | Bourdon David | F-InKind | 10,884.00 | $6.91 | $75,208 |
| 2026-03-09 | Miller Lisa K | A-Award | 26,836.00 | $0.00 | $0 |